DoH and Boehringer Ingelheim Collaborate to Enhance Research on Genetic Disease Drivers
Abu dhabi: The Department of Health – Abu Dhabi (DoH) and Boehringer Ingelheim, a prominent biopharmaceutical company, have announced a strategic partnership aimed at advancing research into the genetic drivers of diseases. This collaboration will uti…